Renjing Bio

Renjing Bio

仁景生物

Renjing Bio

Biotech/Healthcare

Renjing Bio is a drug developer focused on mRNA-based therapeutics, providing clinical research and drug R&D services. Located in Suzhou BioBay, the company is dedicated to researching and developing innovative medicines based on mRNA technology.

Latest round: Pre Series A (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-02-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.